SeekingBiotech03-19 00:30
$Fennec制药(FENC)$
FENC announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI in Europe, Australia, and New Zealand. PEDMARQSI is an approved therapy in the EU and U.K. for the prevention of ototoxicity (hearing loss) induced by cispl...
Fennec制药(FENC)02-02 19:05
$Fennec制药(FENC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-009551 Act: 34 Size: 216 KB 网页链接
Fennec制药(FENC)03-26 07:35
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009068 Size: 5 KB 网页链接
Fennec制药(FENC)03-30 04:25
$Fennec制药(FENC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004383 Act: 34 Size: 10 MB 网页链接
Fennec制药(FENC)03-28 04:35
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009205 Size: 8 KB 网页链接
Fennec制药(FENC)04-04 05:05
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010047 Size: 5 KB 网页链接
Fennec制药(FENC)04-06 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002966 Act: 33 Size: 8 KB 网页链接
Fennec制药(FENC)04-18 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003124 Act: 33 Size: 6 KB 网页链接
Fennec制药(FENC)04-23 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003158 Act: 33 Size: 8 KB 网页链接
Fennec制药(FENC)04-20 04:15
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003137 Act: 33 Size: 7 KB 网页链接